The price of these medicines is greatly reduced!

The body is the capital of the revolution.
Once people are sick, they need to see a doctor and take medicine.
However, for some patients' families, especially those with chronic diseases and tumors, the long-term medical expenses are also a lot of expenses
.
In order to further solve the problem of difficult and difficult medical treatment for patients in our country, relevant departments in China are also taking measures step by step
.
From 2022, news of a large number of drug price cuts has been put on the agenda
.
For example, from January 1, Hubei, Hebei, Yunnan, Liaoning, Chongqing, Beijing and other places across the country have officially implemented the new drug list
.
It is understood that the new version of the National Medical Insurance Drug List has a total of 2,860 kinds of drugs, including 1,486 kinds of Western medicines, 1,374 kinds of proprietary Chinese medicines, and 892 kinds of Chinese herbal medicines
.
These newly included products are all urgently needed and useful medicines for patients, including 20 medicines for chronic diseases such as hypertension, diabetes, hyperlipidemia, and mental illness, 18 medicines for cancer, 15 medicines for anti-infections such as hepatitis C and AIDS, and 7 medicines for rare diseases.
There are 2 kinds of drugs for the treatment of new coronary pneumonia and 12 kinds of drugs in other fields, involving 21 groups that are very common in clinical medicine and have a wide range of benefits.
The coverage of the medical insurance drug list has been greatly expanded, which has further improved the fairness of the medical insurance drug list sex
.
It is expected that in 2022, the cumulative burden on patients will be reduced by more than 30 billion yuan
.
During the medical insurance negotiation, the average price of 67 national medical insurance negotiated drugs was reduced by 61.
71%
.
Among the drugs in the newly promoted drug list, including the previously concerned one-shot price of 699,700 yuan, the treatment drug for spinal muscular atrophy (SMA) rare disease patients "Noxinagen Sodium Injection", the drug After being included in the medical insurance, the price of one injection is 33,000 yuan.
After the reimbursement of basic medical insurance and serious illness insurance, the out-of-pocket expenses of patients will be greatly reduced, which will bring more hope to the families of patients with related rare diseases
.
In addition to the actions at the national level, local governments are also taking active actions.
For example, the varieties of Chinese patent medicines that patients with chronic diseases are very concerned about are also carrying out local centralized procurement, ushering in price reductions
.
At the end of 2021, a 19-province alliance consisting of Hubei, Hebei, Shanxi, etc.
will open bids for the centralized procurement of proprietary Chinese medicines.
A total of 111 proprietary Chinese medicine products and 97 companies have been selected.
The selected varieties include Xuesaitong, Xueshuantong, Ginkgo biloba, etc.
For large varieties of Chinese patent medicines, the average decline was 42.
27%, of which the highest decline reached 82.
63%
.
It is expected that under the price reduction of centralized procurement, patients can save more than 2.
6 billion yuan in drug costs each year
.
According to the quotation information of the selected results of this centralized procurement of proprietary Chinese medicines, the unit price of some varieties is even less than a dime
.
Such as Kangyuan Pharmaceutical's Xuesaitong injection (2ml:100mg, 10 sticks), the product dropped by 60%
.
According to the proposed price, the unit price of the product is less than 0.
7 yuan; Kunyao Group's Xuesaitong Dropping Pills (dropping pills, containing 5 mg of Panax notoginseng saponins, 300 pills) dropped by more than 36% this time.
According to the proposed price, the drug The average price is only 0.
08 yuan; Shenwei Pharmaceutical’s Xuesaitong dripping pills (each pill weighs 45mg, contains 10mg of Panax notoginseng saponins, 210 pills) dropped by about 32%, and the average price is less than a dime after the proposed election.
, only need about 0.
23 yuan
.
In addition, the ginkgo leaves (0.
20g, containing 9.
6mg of total flavonoid glycosides, 2.
4mg of terpenoid lactones, 24 pieces) from Hebei Tiancheng Pharmaceutical Industry and Haikou Qili Pharmaceutical were selected, and the price of a single piece was less than 1 cent
.
Since the end of 2018, when the state organized the “4+7” pilot cities to carry out centralized drug procurement, six batches of drug centralized procurement have been carried out, with an average drop of about 50%, and the centralized procurement varieties have also expanded from chemical generic drugs to insulin
.
With the development of local centralized procurement of proprietary Chinese medicines, the industry generally believes that national procurement of proprietary Chinese medicines will also come, and the prices of proprietary Chinese medicines may be expected to be further reduced by then, benefiting more patients
.